Emmaus Life Sciences, Inc. - Common Stock (OP:EMMA)Price and VolumeDetailed Quote
Top NewsMore News
ProMIS Neurosciences And 2 Other Stocks Under $5 Executives Are Buying
September 19, 2024
PerformanceMore NewsRead More
The Leading Emerging Markets For Market-Beating Gains in 2024
August 25, 2023
BitNile And 2 Other Stocks Under $1 Insiders Are Aggressively Buying
October 13, 2022
Insiders Buying These 5 Penny Stocks
March 03, 2022
Outlook Therapeutics And 4 Other Penny Stocks Bought By Insiders
February 24, 2022
Insiders Buying These 3 Penny Stocks
February 22, 2022
Insiders Buying These 4 Penny Stocks
February 14, 2022
3 Penny Stocks Insiders Are Buying
February 10, 2022
5 Penny Stocks Insiders Are Buying
January 06, 2022
4 Penny Stocks Insiders Are Buying
January 04, 2022
4 Penny Stocks Insiders Are Buying
December 29, 2021
4 Penny Stocks Insiders Are Buying
December 23, 2021
5 Penny Stocks Insiders Are Buying
December 20, 2021
2 Penny Stocks Insiders Are Buying
October 25, 2021
4 Penny Stocks Insiders Are Buying
September 28, 2021
3 Penny Stocks Insiders Are Buying
September 03, 2021
3 Penny Stocks Insiders Are Buying
August 06, 2021
3 Penny Stocks Insiders Are Buying
August 03, 2021
Frequently Asked QuestionsIs Emmaus Life Sciences, Inc. - Common Stock publicly traded?
Yes, Emmaus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does Emmaus Life Sciences, Inc. - Common Stock trade on?
Emmaus Life Sciences, Inc. - Common Stock trades on the OTC Traded
What is the ticker symbol for Emmaus Life Sciences, Inc. - Common Stock?
The ticker symbol for Emmaus Life Sciences, Inc. - Common Stock is EMMA on the OTC Traded
What is the current price of Emmaus Life Sciences, Inc. - Common Stock?
The current price of Emmaus Life Sciences, Inc. - Common Stock is 0.0230
When was Emmaus Life Sciences, Inc. - Common Stock last traded?
The last trade of Emmaus Life Sciences, Inc. - Common Stock was at 03/20/25 09:52 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|